Literature DB >> 25622489

Increasing incidence of tick-borne encephalitis and its importance in the Slovak Republic.

Erik Dorko, Kvetoslava Rimárová, Peter Kizek, Milan Stebnický, L'ubica Zákutná.   

Abstract

Tick-borne encephalitis (TBE) is caused by tick-borne encephalitis virus (TBEV), a virus species of the genus Flavivirus within the Flaviviridae family. In Western Europe, TBEV is transmitted primarily by the Ixodes ricinus (I. ricinus) tick. During the last 30 years, there has been a continued increase in human cases of TBE in Europe. A total number of 102 cases in Slovakia was reported in 2012 (1.89/100,000), with two local outbreaks after the ingestion of raw milk and dairy products. Active vaccination is the most effective method of preventing TBE. According to the available data in Slovakia from 2012, 8,491 children under 15 years of age were vaccinated that year, which, when compared to 2009 with approximately 17,000 vaccinated children, represents a decrease of more than 50%. The data on vaccination of adults are not available, but the estimated vaccination coverage in Slovakia is around 1% (1.3/100,000). The education of the population is also an important precautionary measure in the prevention of tick-borne illnesses.

Entities:  

Mesh:

Year:  2014        PMID: 25622489     DOI: 10.21101/cejph.a3939

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  2 in total

1.  Epidemiological patterns of tick-borne encephalitis in Lithuania and clinical features in adults in the light of the high incidence in recent years: a retrospective study.

Authors:  D Radzišauskienė; K Žagminas; L Ašoklienė; A Jasionis; R Mameniškienė; A Ambrozaitis; L Jančorienė; D Jatužis; I Petraitytė; E Mockienė
Journal:  Eur J Neurol       Date:  2017-12-06       Impact factor: 6.089

2.  Phylogenetics of tick-borne encephalitis virus in endemic foci in the upper Rhine region in France and Germany.

Authors:  Malena Bestehorn; Sebastian Weigold; Winfried V Kern; Lidia Chitimia-Dobler; Ute Mackenstedt; Gerhard Dobler; Johannes P Borde
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.